Anabolic Steroids, Stimulants & 'Doping'
- PERFORMANCE- and APPEARANCE-ENHANCING DRUGS/substances ('DOPING') include ANABOLIC-ANDROGENIC STEROIDS (AAS) and STIMULANTS, as well as GROWTH HORMONE, DIURETICS (for weight/masking), erythropoietin/blood doping, and various SUPPLEMENTS - an ethical and health issue in sport, and recognising their use is important so athletes receive appropriate care and education.
- ANABOLIC-ANDROGENIC STEROIDS increase muscle mass and strength but cause a wide range of SERIOUS, sometimes PERMANENT, ADVERSE EFFECTS: CARDIOVASCULAR (cardiomyopathy, hypertension, dyslipidaemia, thrombosis), HEPATIC (cholestasis and hepatic tumours, especially with oral 17-alpha-alkylated agents), RENAL disease, ENDOCRINE (testicular atrophy/hypogonadism, gynaecomastia, virilisation in women), and PSYCHIATRIC effects (aggression/'roid rage', mood disturbance, dependence), plus acne and premature physeal closure/stunted growth in adolescents.
- The key ORTHOPAEDIC adverse effect is an increased risk of TENDON RUPTURE: anabolic steroids strengthen the muscle disproportionately and may weaken/alter the tendon, predisposing to ruptures - classically of the PECTORALIS MAJOR, and also the Achilles, quadriceps/patellar and biceps tendons - so unexpected or bilateral tendon ruptures in a muscular athlete should raise the possibility of AAS use.
- STIMULANTS (e.g. amphetamines, certain pre-workout agents) enhance alertness and performance but carry CARDIOVASCULAR risks (palpitations, hypertension, arrhythmia, and a contribution to sudden cardiac events) and increase the risk of HEAT illness/dehydration; signs of doping more broadly can mimic other health concerns (palpitations, acne, mood change, headaches, cramps).
- According to PubMed, doping can lead to SEVERE and sometimes PERMANENT ORGAN DAMAGE - including liver, kidney and heart disease - and recognising appearance/performance-enhancing substance use is important so that athletes (including adolescents) receive the care, treatment and EDUCATION needed to reduce these health risks.
- MANAGEMENT and the wider response are RECOGNITION (clinical signs, the orthopaedic clue of tendon rupture), honest counselling and treatment of the health consequences, compliance with the ANTI-DOPING (WADA) framework, and EDUCATION/PREVENTION - fostering an anti-doping culture among athletes, coaches and clinicians; the orthopaedic surgeon's role includes recognising the doping athlete behind a tendon rupture and addressing the underlying issue.
- “Doping = performance/appearance-enhancing substances: ANABOLIC-ANDROGENIC STEROIDS, STIMULANTS, GH, diuretics, supplements (WADA-prohibited).
- “Anabolic steroids: strength gain BUT serious harms - cardiovascular (cardiomyopathy/hypertension/dyslipidaemia), hepatic (cholestasis/tumours - oral 17-alkylated), endocrine (hypogonadism/gynaecomastia/virilisation), psychiatric ('roid rage'/dependence), adolescent physeal closure.
- “KEY orthopaedic clue: increased TENDON RUPTURE risk (pectoralis major, Achilles, quadriceps) - suspect AAS in an unexpected/bilateral tendon rupture in a muscular athlete. Stimulants -> cardiovascular/heat risk. Response = recognition + anti-doping (WADA) + education/prevention; severe/permanent organ damage.
Anabolic steroids: cardiovascular (cardiomyopathy/hypertension), hepatic (cholestasis/tumours), endocrine (hypogonadism/gynaecomastia/virilisation), psychiatric ('roid rage'/dependence); adolescent physeal closure.
Increased tendon rupture risk (pectoralis major, Achilles, quadriceps) - suspect AAS in an unexpected/bilateral rupture in a muscular athlete. Stimulants -> cardiovascular/heat risk.
Substances, Harms & Response
'Doping' is the use of performance/appearance-enhancing substances - principally anabolic-androgenic steroids (AAS) and stimulants, also growth hormone, diuretics and supplements. AAS increase muscle mass and strength but cause serious, sometimes permanent harms: cardiovascular (cardiomyopathy, hypertension, dyslipidaemia, thrombosis), hepatic (cholestasis/tumours - oral 17-alkylated agents), renal, endocrine (hypogonadism, gynaecomastia, virilisation), psychiatric ('roid rage', mood, dependence), and physeal closure in adolescents. The key orthopaedic clue is an increased tendon rupture risk - classically the pectoralis major (also Achilles, quadriceps/patellar) - so an unexpected or bilateral tendon rupture in a muscular athlete should raise AAS use. Stimulants add cardiovascular and heat risk. The response is recognition, treatment of harms, anti-doping (WADA) compliance and education/prevention.
For the orthopaedic surgeon, performance-enhancing drug use often becomes relevant through its musculoskeletal consequence: anabolic-androgenic steroids strengthen muscle disproportionately to tendon and alter tendon properties, predisposing to rupture, so an unexpected, spontaneous or bilateral tendon rupture - classically of the pectoralis major, but also the Achilles, quadriceps/patellar or biceps - in a notably muscular athlete should prompt consideration of anabolic-steroid use. Recognising this matters not only for the injury but for the athlete's wider health, because doping can cause severe and sometimes permanent organ damage - cardiomyopathy and other cardiovascular disease, hepatic cholestasis and tumours, renal disease - and serious endocrine and psychiatric effects, with stimulants adding cardiovascular and heat-illness risk; in adolescents, anabolic steroids can cause premature physeal closure and stunted growth. The clinician's role is therefore to recognise the doping athlete, treat the injury and the health consequences honestly, counsel and educate, and work within the anti-doping framework to foster an anti-doping culture - rather than treating the tendon rupture in isolation.
Evidence & Key Studies
Appearance- and performance-enhancing drugs and substances - recognition and prevention
- Commonly used appearance/performance-enhancing substances ('doping') include anabolic-androgenic steroids, stimulants, diuretics, growth hormone and supplements.
- Signs and symptoms can mimic other health concerns (palpitations, stunted growth, acne, severe headaches, muscle cramps, dizziness, dehydration), and some effects are severe and long-term.
- Doping can lead to severe and sometimes permanent organ damage, including liver, kidney and heart disease; recognition, treatment and education/prevention (fostering an anti-doping culture) are important.
According to PubMed, the common performance/appearance-enhancing substances (anabolic-androgenic steroids, stimulants, diuretics, growth hormone, supplements), the fact that their signs can mimic other conditions, and that doping can cause severe and sometimes permanent organ damage (liver, kidney, heart) with recognition, treatment and education/prevention being important, come from the cited Siegmund review. The specific adverse- effect profile of anabolic-androgenic steroids (cardiovascular/hepatic/endocrine/psychiatric, adolescent physeal closure), the key orthopaedic association with TENDON RUPTURE (pectoralis major, Achilles, quadriceps), the cardiovascular/heat risks of stimulants, and the anti-doping (WADA) framework are standard, well-established teaching. (See also our Pectoralis Major Rupture, Achilles Tendon Rupture and Sudden Cardiac Death in Athletes topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A very muscular gym athlete sustains a pectoralis major rupture with little provocation. What should you suspect, and what are the wider concerns?”
Mnemonics & Memory Aids
STEROIDS
Hook:STEROIDS: Stimulants/Steroids, Tendon rupture, Endocrine effects, 'Roid rage, Organ damage, Identify the athlete, Doping (WADA)/education, Stimulant CV/heat risk.
The substances
- Anabolic-androgenic steroids; stimulants
- Growth hormone; diuretics (weight/masking); erythropoietin/blood doping; supplements
- WADA-prohibited; an ethical and health issue in sport
Anabolic-steroid harms
- Cardiovascular: cardiomyopathy, hypertension, dyslipidaemia, thrombosis
- Hepatic (cholestasis/tumours - oral 17-alkylated); renal disease
- Endocrine (hypogonadism/gynaecomastia/virilisation); psychiatric ('roid rage'/dependence); adolescent physeal closure
Orthopaedic relevance
- Increased TENDON RUPTURE risk (pectoralis major, Achilles, quadriceps/patellar, biceps)
- Suspect AAS in an unexpected/bilateral rupture in a muscular athlete
- Stimulants: cardiovascular (palpitations/arrhythmia) + heat-illness risk
Response
- Recognition (signs can mimic other conditions)
- Treat injury + health consequences; honest counselling
- Anti-doping (WADA) framework + education/prevention (anti-doping culture)